Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.
about
Atypical hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesProphylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome.Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsThrombotic microangiopathy and associated renal disorders.Assesment, treatment and prevention of atypical hemolytic uremic syndrome.Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.The importance of genetic mutation screening to determine retransplantation following failed kidney allograft from recurrent atypical haemolytic ureamic syndromeAtypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literatureAtypical Hemolytic Uremic Syndrome: A Brief Review.Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management.Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation.Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome.Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.
P2860
Q21202864-8B3EB7C0-C983-440B-88C8-F04ACBFB73BAQ24613517-C3C63563-37A2-430D-9E7E-C0638B8B3233Q24613907-9BFD2095-545D-4D11-B340-CB84B86AA92DQ26796453-F5C48D1F-B14E-4A83-B20E-E0E1DF34B7A7Q33384133-A25E53EA-4EA4-43CE-A94A-A63F38AC647EQ33393107-997133BB-2619-4E7B-84E8-59C9B18686DEQ33396013-797C0E93-8CD4-4CB7-A14B-E1AFC6C63B90Q33400211-0898939B-495E-44CA-806A-35E26FEFCE5EQ33402372-57148216-C646-4999-9369-56C3917819FCQ33405916-CE3C343E-9176-494D-B637-EBF2F27C1B65Q33411421-D4B4F146-08A1-424F-9D87-DE1B2FDCC195Q33414227-EE906946-9AE5-4FFB-80AD-61750E1924E5Q33419812-45B07AA7-4334-40B3-A808-6512FCDB2618Q33442794-11AE8EDC-7683-4265-A728-B5FEDACCA126Q39112532-86028910-B916-452C-B418-4661105C9D7AQ42345295-FCDF1F88-0A67-476A-BE3F-F47A2D1878EAQ42553788-394C78AB-A143-499C-BD40-EDBE2F67A121Q51353137-F8F8A8C1-EBF5-4A62-929B-2F832B714C11
P2860
Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@ast
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@en
type
label
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@ast
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@en
prefLabel
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@ast
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@en
P2093
P2860
P1433
P1476
Plasma therapy in atypical hae ...... mily with a factor H mutation.
@en
P2093
Jean Claude Davin
Lisa Strain
Tim H J Goodship
P2860
P2888
P304
P356
10.1007/S00467-008-0833-Y
P577
2008-05-16T00:00:00Z
P5875
P6179
1037568386